Loading viewer...
investor_presentation
Format: PDF investor_presentation
Immunic Therapeutics is developing a pipeline of next-generation selective oral therapies for chronic inflammatory and autoimmune diseases. The presentation outlines the company's lead product candidates including IMU-838, IMU-935, and IMU-856, with details on clinical trial timelines and commercial strategy.
investor_presentation
29 Pages
The Manitowoc Company, Inc.
ANZ ESG Presentation 2020 - Environmental Social Governance
investor_presentationinvestor_presentation
51 Pages
Australia and New Zealand Banking Group
Adani Energy Solutions Limited Equity Presentation 2023
investor_presentationinvestor_presentation
54 Pages
Adani Energy Solutions Limited